Mettler-Toledo International (NYSE:MTD) CFO Shawn Vadala Sells 1,025 Shares

Mettler-Toledo International, Inc. (NYSE:MTD) CFO Shawn Vadala sold 1,025 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $1,452.00, for a total value of $1,488,300.00. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,678,176. The trade was a 16.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shawn Vadala also recently made the following trade(s):

• On Tuesday, November 25th, Shawn Vadala sold 1,000 shares of Mettler-Toledo International stock. The shares were sold at an average price of $1,511.00, for a total value of $1,511,000.00.
• On Tuesday, November 11th, Shawn Vadala sold 1,895 shares of Mettler-Toledo International stock. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,485.25 on Thursday. The stock has a market capitalization of $30.34 billion, a price-to-earnings ratio of 37.61, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. The business has a 50-day moving average of $1,360.59 and a 200 day moving average of $1,269.64. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter in the prior year, the company earned $10.21 earnings per share. The business’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Bank of America increased their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Citigroup upped their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $1,406.50.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc grew its stake in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 8 shares during the last quarter. SJS Investment Consulting Inc. boosted its holdings in shares of Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the period. WPG Advisers LLC acquired a new stake in shares of Mettler-Toledo International in the first quarter valued at approximately $41,000. NewSquare Capital LLC grew its position in shares of Mettler-Toledo International by 94.4% during the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 17 shares during the last quarter. Finally, MV Capital Management Inc. increased its holdings in shares of Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 12 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.